Impact of sample preparation upon intracellular metabolite measurements in 3D cell culture systems. by Mathon, C. et al.
Vol.:(0123456789) 
Metabolomics (2019) 15:92 
https://doi.org/10.1007/s11306-019-1551-0
ORIGINAL ARTICLE
Impact of sample preparation upon intracellular metabolite 
measurements in 3D cell culture systems
Caroline Mathon1,2  · David Bovard1  · Quentin Dutertre1 · Sandra Sendyk1 · Mark Bentley1  · Julia Hoeng1  · 
Arno Knorr1
Received: 3 January 2019 / Accepted: 29 May 2019 / Published online: 12 June 2019 
© The Author(s) 2019
Abstract
Introduction Interest in cell culture metabolomics has increased greatly in recent years because of its many potential applica-
tions and advantages (e.g., in toxicology). The first critical step for exploring the cellular metabolome is sample preparation. 
For metabolomics studies, an ideal sample preparation would extract a maximum number of metabolites and would enable 
reproducible, accurate analysis of a large number of samples and replicates. In addition, it would provide consistent results 
across several studies over a relatively long time frame.
Objectives This study was conducted to evaluate the impact of sample preparation strategies on monitoring intracellular 
metabolite responses, highlighting the potential critical step(s) in order to finally improve the quality of metabolomics studies.
Methods The sample preparation strategies were evaluated by calculating the sample preparation effect, matrix factor, 
and process efficiency (PE) for 16 tobacco exposition-related metabolites, including nicotine, nicotine-derived nitrosamine 
ketone, their major metabolites, and glutathione, using isotopically-labelled internal standards. Samples were analyzed by 
liquid chromatography (LC) coupled to high-resolution mass spectrometry (HRMS).
Results A sample drying step increased losses or variability for some selected metabolites. By avoiding evaporation, good 
sample preparation recovery was obtained for these compounds. For some metabolites, the cell or culture type impacted PE 
and matrix factor.
Conclusion In our sample preparation protocol, the drying–reconstitution step was identified as the main cause of metabolite 
losses or increased data variability during metabolomics analysis by LC-HRMS. Furthermore, PE was affected by the type 
of matrix. Isotopologue internal standards fully compensate losses or enhancements.
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1 Introduction
Characterization of the cellular metabolome, represented by 
intermediates and end products of all enzymatic reactions in 
a cell, enables the evaluation of cellular biochemical activ-
ity/networks. This information can predict molecular physi-
ology and phenotypic changes in an organism (Töpfer et al. 
2015). Stimuli or changes (e.g., environment, virus, food 
intake, smoking) induce responses at the metabolite level 
because of upstream modifications to DNA, mRNA, and 
proteins (Ivanisevic et al. 2013; Vinaixa et al. 2016; Worley 
and Powers 2013).
Metabolomics approaches may be categorized as follows: 
(i) An untargeted approach encompasses as many metabo-
lites as possible to provide a comprehensive analysis. For 
these global analyses, the entire workflow must be non-
selective, reproducible, and unbiased in order to preserve 
the integrity of cellular metabolites and include as many 
metabolites as possible (Cala and Meesters 2017; Ulmer 
et al. 2015). Metabolite abundances or relative responses are 
reported. (ii) A targeted approach is focused on a limited list 
of metabolites. In this case, sample preparation and analyti-
cal methods are optimized for specific compounds, which are 
absolutely quantified using calibration curves and internal 
standards for each metabolite. (iii) A semi-targeted approach 
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lies between the targeted and untargeted approaches. Many 
metabolites are screened and semi-quantified, using single 
calibration curves for multiple compounds (Broadhurst et al. 
2018).
For toxicological assessment, changes in metabolic pro-
files and their relationship to various biochemical path-
ways are investigated. Untargeted approaches have been 
used for this purpose, for instance, to explore the global 
impact of environmental chemical contaminants on earth-
worms (Griffith et al. 2018) or on human cells (Hartung 
et al. 2017), or to assess the impact of tobacco exposure 
on in vitro systems (Iskandar et al. 2017; Kogel et al. 
2016; Zanetti et al. 2017). For in vitro toxicology studies, 
two-dimensional (2D) cell cultures have been the most 
commonly investigated systems for decades. Currently, 
however, human three-dimensional (3D) tissue cultures 
are widely regarded as more relevant than 2D monolayer 
cell cultures for in vitro toxicological assessments. In 2D 
culture systems, the extracellular matrix and cell–cell and 
cell–matrix interactions, all essential for differentiation, 
proliferation, and cellular functions, are not present. In 
contrast, 3D cultures are sometimes composed of several 
cell types where cell–cell and cell–matrix interactions are 
formed, recreating physiological tissue structure, enabling 
cell differentiation, and finally, potentially increasing drug 
susceptibility (Bovard et al. 2017; Ravi et al. 2015). Sev-
eral 3D tissues mimicking human organs are commercially 
available or can be generated by investigators in-house. 
Bronchial 3D organotypic tissues can be prepared starting 
from primary airway epithelial human cells grown at the 
air–liquid interface (ALI) and seeded on a collagen-based 
support: in these conditions, cells differentiate to form 
a functional bronchial tissue composed of basal, goblet, 
and ciliated cells (Fig. 1a) (Karp et al. 2002). Such 3D 
bronchial tissue models have morphological and meta-
bolic characteristics that are comparable with those of 
large human airways (Baxter et al. 2015; Pezzulo et al. 
2011). Furthermore, when bronchial tissue cultures are 
developed and maintained at the ALI, they can be exposed 
to various aerosols, including cigarette smoke or a can-
didate modified risk tobacco product aerosol, mimicking 
in vivo inhalation exposure (Iskandar et al. 2017). These 
toxicological investigations have greatly improved over the 
last few years thanks to the development of new 3D mod-
els that better mimic lung function. In addition to bron-
chial tissues, liver spheroids were also investigated, as the 
liver is the most metabolically active organ (Fathi et al. 
2017). Liver function can be mimicked by liver spheroids 
composed of HepaRG™ cells (Fig. 1b). HepaRG™ cells 
are terminally differentiated hepatic cells derived from a 
human hepatic progenitor cell line, retaining many char-
acteristics of primary human hepatocytes. The spheroid 
organization enables close contact between cells as well 
as polarization and formation of bile canaliculi (Alepee 
et al. 2014). In addition to these morphological advan-
tages, 3D organization of liver cells leads to increased 
albumin secretion, the ability for cytochrome P450 family 
induction and longer cell survival than 2D cultures (Taka-
hashi et al. 2015). As described by Groell et al. 3D cell 
cultures represent a perfect compromise between 2D and 
animal models (Groell et al. 2018).
For untargeted cellular metabolome characterization, 
sample preparation must be non-discriminative and precise. 
The protocol must also maintain sample stability, because 
intracellular metabolites can be rapidly degraded or metabo-
lized by enzymatic reactions, and must minimize contami-
nants in both sample and detector (Drouin et al. 2018; Pinu 
et al. 2017). Precise results from single-time-point analyses 
or kinetic studies are necessary in order to obtain an accu-
rate snapshot of the metabolome. Cell extracts must be rap-
idly and reproducibly quenched to stop metabolic activity 
to ensure consistent results across many samples and sev-
eral studies over an extended time frame. Compound loss 
or modification caused by chemical or enzymatic reactions 
occurring during sample harvest, preparation, and analysis 
must be minimized. Changes occurring in the autosampler 
during chromatographic analysis can be monitored by com-
paring the signal responses with injection order and can be 
corrected using quality control (QC) samples or by includ-
ing appropriate stable isotopically labelled internal stand-
ards (ISTD) (Broadhurst et al. 2018). ISTDs can be used 
to compensate for changes occurring at any time after they 
are added to the samples, even during sample preparation 
(Pinu et al. 2017). It is of paramount importance to minimize 





a NHBE ALI tissue
b HepaRG™ spheroid
100µm 
Fig. 1  a Representative histological section of NHBE ALI tissues, 
stained with hematoxylin, eosin, and Alcian blue. Magnification ×20. 
The in  vitro tissue was composed of ciliated cells (black triangle), 
goblet cells (empty diamond), and basal cells (black arrow). b Rep-
resentative bright-field images of HepaRG™ spheroid. Magnification 
×10
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difficult to evaluate, by decreasing duration of sampling and 
by placing samples into low temperature storage as soon as 
possible (Pinu et al. 2017).
To our knowledge, there are no harmonized procedures 
for sample preparation of 3D cell cultures for untargeted 
metabolomics. More generally, standard protocols for sam-
ple preparation have not been fully established, mostly 
because metabolomics is a rapidly evolving technique uti-
lizing a broad range of analytical techniques and sample 
matrices and measuring metabolites with a wide variety of 
physical and chemical properties (Bi et al. 2013; Daskalaki 
et al. 2018; Ulmer et al. 2015). Nevertheless, one recent 
guideline for untargeted metabolomics analysis is avail-
able (Broadhurst et al. 2018). Although sample preparation 
is a crucial step, as it can affect the entire study outcome, 
it is often neglected, and evaluation of its impact is rarely 
considered (Cuykx et al. 2017; Dettmer et al. 2011; Marti-
novic et al. 2018; Römisch-Margl et al. 2012; Sapcariu et al. 
2014). Intracellular metabolites were extracted using freeze-
thawing cycles or homogenization, with and without a dry-
ing–reconstitution step. Sample extracts were analyzed by 
liquid chromatography (LC) coupled to high-resolution mass 
spectrometry (HRMS). To evaluate the reproducibility of 
the generic analytical approach, we chose 16 chemicals and 
eight ISTDs specific to our research area. These compounds 
(Table 1), all related to tobacco exposure, included nicotine, 
nicotine-derived nitrosamine ketone (NNK), and their major 
metabolites as well as glutathione (GSH), a biomarker of 
oxidative stress. Of these, nicotine, NNK, and their metabo-
lites are either abundant in tobacco-derived aerosols (nico-
tine) or have carcinogenic potential (NNK) (Konstantinou 
et al. 2018). Understanding the metabolism pathways for 
xenobiotics, such as nicotine and its metabolites, the major 
markers for cigarette smoke exposure, requires precise 
metabolite analyses, either at individual time points or in 
kinetic studies. Based on this compound pallet, method was 
evaluated by calculating the effect of the sample preparation, 
matrix factor, and process efficiency (PE) for the selected 
metabolites and ISTDs for bronchial and hepatic 3D cell 
cultures.
2  Materials and methods
2.1  Reagents and chemicals
LC coupled to mass spectrometry (MS)-grade water and 
methanol (LC/MS Chromasolv) were supplied by Hon-
eywell Riedel-de Haën™ (Seelze, Germany). Analytical 
standards, ISTDs, and formic acid were supplied by Sigma 
Aldrich (St. Louis, MO, USA), Toronto Research Chemi-
cals (Ontario, Canada), TLC PharmaChem (Ontario, Can-
ada), or Santa Cruz Biotechnology (Dallas, TX, USA), 
depending on availability (details for analytes and ISTDs 
are presented in Table 1).
The standard and ISTD solutions (commercially 
obtained or prepared in the laboratory from powder), 
at approximately 1 mg/mL, were stored at − 20 °C and 
diluted in methanol/water (4:1 v/v) on the day of analy-
sis for spiking mixtures and calibration curves. Calibra-
tion levels ranged over three orders of magnitude for each 
metabolite, and concentrations were selected based on MS 
sensitivity of each metabolite and its expected concentra-
tions in the samples.
2.2  HepaRG™ spheroids
HepaRG™ cells (Ref. HPRGC10, ThermoFisher Sci-
entific) were first thawed in William’s E medium (Ref. 
12551032, ThermoFisher) supplemented with Glu-
taMAX™ (Ref. 35050061, ThermoFisher) and Hep-
aRG™ Thaw, Plate & General Purpose Medium Supple-
ment (Ref. HPRG770, ThermoFisher). After thawing, 
25,000 cells were seeded in each well of an ultra-low 
adhesion 96-well plate (Ref. 4520, Corning, NY, USA). 
The 96-well plates were kept in the incubator at 37 °C for 
4 days before medium replacement. On the fourth day, 
cells formed dense aggregates with a visible extracellular 
matrix confirming spheroid formation. Thereafter, the cell 
culture medium was renewed every 2–3 days. Spheroids 
were used once mature, approximately 1 week after thaw-
ing HepaRG™ cells.
2.3  NHBE ALI tissues
Normal human bronchial epithelial (NHBE) ALI tissues 
were prepared following a procedure described by STEM-
CELL Technologies (PneumaCult™ Medium, Document 
#29252; STEMCELL Technologies, Vancouver, Canada). 
Briefly, NHBE cells (Lonza, Basel, Switzerland) were cul-
tured in T75-flasks using PneumaCult™-EX PLUS medium 
(Ref. 05040, STEMCELL Technologies) at 37  °C with 
5%  CO2 and 90% relative humidity. Once the cells were 
80% confluent, they were detached from the flask using 
trypsin-ethylenediaminetetraacetic acid (EDTA) (Ref. 
CC-5034, Lonza), and 50,000 cells were seeded on a Col-
lagen I-coated Transwell® insert (Corning®, Corning, NY, 
USA). Both apical and basal sides of the inserts were filled 
with PneumaCult™-EX PLUS medium and maintained for 
3 days. Subsequently, the culture was airlifted by removing 
the apical medium; the basal medium was replaced with the 
PneumaCult™-ALI medium (STEMCELL Technologies). 
Tissues were used for experiments starting from day 28 after 
airlift.
 C. Mathon et al.
1 3
92 Page 4 of 11
2.4  Sample preparation
The sample preparation workflow is shown in Fig. 2. Two 
extraction procedures were evaluated in parallel, based on 
either freeze-thawing or homogenization. Other than the 
extractions, all other steps were common to all samples.
After removal of the culture medium, cells were washed 
twice with 0.5  mL phosphate-buffered saline (PBS) 
without calcium chloride and magnesium chloride (Ref. 
D8537, Sigma).
For both extraction procedures, washed cell cultures 
were quenched with 150 µL cold (− 20 °C) methanol/
water (4:1 v/v) containing the ISTDs and, for spiked sam-
ples, the standards. For the HepaRG™ spheroids, which 
were non-adherent, spheroids and solvent were transferred 
directly into an Eppendorf tube for further extraction. As 
the NHBE ALI tissues were adherent and not homogenous, 
tissues were harvested from the inserts after quenching by 
scraping into cold methanol/water, on ice.
Table 1  List of the major nicotine, NNK, and GSH metabolites investigated, with their corresponding abbreviations, ISTDs, CAS number, for-
mula, molecular ion m/z in positive electrospray ionization, retention times, and suppliers
ISTDs isotopically labelled internal standards, SCBT Santa Cruz Biotechnology, TRC Toronto Research Chemicals
Categories Metabolites Abbreviations ISTDs CAS Formula m/z [M+H]+ tR Suppliers
Nicotine Cotinine  D3 Cot  D3 N/A 110952-70-0 C10H5D7N2O 180.12107 8.0 Sigma-Aldrich
3-hydroxy-cotinine-O-β-
glucuronide
OH Cot-O-gluc. Cot  D3 132929-88-5 C16H20N2O8 369.12924 3.9 TRC 
Cotinine Cot Cot  D3 486-56-6 C10H12N2O 177.10224 8.0 Sigma-Aldrich
Cotinine-N-oxide Cot-N-Ox Cot  D3 36508-80-2 C10H12N2O2 193.09715 7.5 TLC PharmaChem
Nicotine  D3 Nic  D3 N/A 69980-24-1 C10D3H11N2 166.14181 8.4 Sigma-Aldrich
Nicotine Nic Nic  D3 54-11-5 C10H14N2 163.12298 8.4 Sigma-Aldrich
Nicotine-N-β-
glucuronide  D3
Nic-N-gluc.  D3 N/A 329002-74-6 C16H19D3N2O6 342.17389 1.8 SCBT
Nicotine-N-glucuronide Nic-N-gluc. Nic-N-Gluc.  D3 152306-59-7 C16H22N2O6 339.15506 1.8 TRC 
Nicotine-N-oxide  D3 Nic-N-ox  D3 N/A 491-26-9 C10H11D3N2O 182.13672 8.8 TLC PharmaChem
Nicotine-N-oxide Nic-N-ox Nic-N-ox  D3 491-26-9 C10H14N2O 179.11789 8.8 TLC PharmaChem
Nornicotine  D4 Nornic  D4 N/A 66148-18-3 C9H8  D4N2 153.13243 6.0 TRC 
























HPB  D2 N/A 154603-21-1 C9H9D2NO2 168.09881 8.9 TRC 
1-(3-Pyridyl)-1,4-butane 
diol
Diol HPB  D2 76014-83-0 C9H13NO2 168.10191 3.2 TRC 
1-(3-Pyridyl)-1-butanol-
4-carboxylic acid




OPBA HPB  D2 4192-31-8 C9H9NO3 180.06552 9.0 TRC 
4-Hydroxy-1-(3-
pyridyl)-1-butanone
HPB HPB  D2 59578-62-0 C9H11NO2 166.08626 8.9 TRC 
GSH Glutathione reduced 
13C215N
GSH 13C2 15N N/A 815610-65-2 13C215N  C8H17N2O6S 311.09483 2.7 Sigma-Aldrich
Glutathione reduced GSH GSH 13C2 15N 70-18-8 C10H17N3O6S 308.09108 2.7 Sigma-Aldrich
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2.4.1  Freeze‑thawing extraction procedure
After quenching, cells were frozen using dry ice for 20 min 
and then agitated for 10 min at 30 °C and 800 rpm on a 
ThermoMixer C (Eppendorf, Schönenbuch, Switzerland). 
This process was repeated for two cycles.
2.4.2  Homogenization extraction procedure
Zirconium beads (1.4 mm) were added to the quenched 
cells, in Eppendorf tubes, and tubes were placed in cold 
homogenizer blocks (pre-cooled to −20 °C). Samples were 
disrupted with a tissuelyser (QIAGEN, Hombrechtikon, 
Switzerland) for 2 min at 30 Hz.
After extraction, to remove proteins and other cell 
debris, the extracts were centrifuged for 10  min at 
16’800×g (4° C). Supernatants were transferred into vials 
(60 µL) for LC-HRMS analysis.
For the drying–reconstitution step, instead of transfer-
ring the aliquot extracts to LC-HRMS vials directly, ali-
quots (100 µL) were dried either under a gentle  N2 stream 
at room temperature, or with a Speedvac at 30 °C (Christ, 
Osterode, Germany). The dried extracts were then recon-
stituted in 100 µL methanol/water, (4:1 v/v). After cen-
trifugation for 10 min at 4 °C, 16’800×g, supernatants 
were transferred into vials (60 µL) for LC-HRMS analysis.
2.5  Experimental design
To evaluate sample preparation, two extraction protocols 
(i.e. freeze-thawing or homogenization), were performed 
and compared for standard solutions and for each cell type 
(i.e. NHBE ALI tissues and HepaRG™ spheroids) (Figs. 2, 
3). For both protocols the extraction solvent was a mixture 
of methanol–water (80:20 v/v).
Concentrations measured in pure standard solutions 
(Fig. 3a) were compared to concentrations measured in 
standard solution going through the extractions (Fig. 3b), as 
well as concentrations measured in the spiked cells (Fig. 3c).
For each sub-group (e.g., pure standard, spiked HepaRG 
cells extracted with freeze–thaw procedure, …), six repli-
cates were prepared and injected once.
2.6  LC‑HRMS instrumentation
All analyses were performed using an Accela 1250 ultra-
high performance LC system coupled to a Q-Exactive 
HRMS equipped with a heated electrospray ionization 
source (Thermo Fisher Scientific, Bremen, Germany).
Metabolite separation was performed using two comple-
mentary stationary phases in series, comprising a Biobasic 
anion-exchange column (50 mm × 2.1 mm, 5 µm particle 
size, Thermo Scientific) followed by a Kinetex® pentafluo-
rophenyl column (150 mm × 2.1 mm, 2.6 µm particle size, 
100 Å, Phenomenex, Basel, Switzerland). Samples were 
analyzed in positive ionization mode using 10 mM ammo-
nium formate buffer, pH 3.5 (eluent A), and methanol/water/
formic acid (95:5:0.1, v/v/v) (eluent B). The elution gradient 
was: held at 99% A for 2 min, 99% A to 55% A in 8 min, 
Cells / Tissues
~300,000 cells
1. Washing the pellet 
2* 0.5 mL PBS
2. Quenching 
Cold Methanol-H2O with ISTDs
4. Centrifugation 
16’800 × g, 10 min, 4°C 
6. Transfer supernatant to LC vial
3. Freeze-Thawing
Extraction 
2* 20 min on dry ice
2* 10 min mixing
5. Reconstitution
Dry supernatant gentle N2 
Reconstitution Methanol-H2O 
Centrifugation 16’800 × g, 10 min, 4°C 
3. Homogenization
Extraction 
2 min, 30 HZ
Cooled blocks
Fig. 2  Sample preparation workflow for freeze-thawing- and homoge-
nization-based procedures. In both protocols, all steps were common, 
other than the extraction step (step 3). Because of the significant sig-
nal decrease or variability caused by drying–reconstitution, this step 










































Fig. 3  Assay procedure to evaluate sample preparation methods by 
measuring sample preparation effect (b/a), matrix factor (c/b), and PE 
(c/a). Adapted from Mathon et al. (2013) and Noga et al. (2018)
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then decreasing to 0% A in 3 min and held at 100% B for 
2 min. Initial conditions were restored between samples by 
returning to 99% A over 1 min, followed by equilibration for 
an additional 4 min. The flow rate was 0.28 mL/min, the LC 
column oven was maintained at 40 °C, the injection volume 
was 1 µL and the autosampler was maintained at 10 °C.
The HRMS system was calibrated and tuned according 
to the manufacturer’s recommendations using the tune mix 
(REF 88323, ESI positive ion calibration solution, Fisher 
Scientific, Loughborough, UK) Nitrogen (purity > 99.999%) 
was used as a sheath gas and auxiliary gas at a flow of 50 and 
15 arbitrary units, respectively. Auxiliary gas and capillary 
temperatures were 350 °C and 300 °C, respectively. Spray 
voltage was 3.00 kV.
Full scan acquisition mode (m/z 60–900) at a mass resolv-
ing power of 70,000 (full width at half maximum, FWHM) 
at m/z 200 with an automatic gain control (AGC) target set at 
 5e5, and a maximum inject time of 150 ms was used. For tan-
dem mass spectrometry (MS/MS) metabolite identification, 
the following conditions were used: data-dependent MS/MS 
top three of each scan at 17,500 (FWHM) at m/z 200, with 
an AGC target set at  5e4 and a maximum injection time of 
150 ms, with stepped normalized collision energies set at 25, 
50, and 75 eV with an isolation window of 1 m/z.
2.7  Data processing and data analysis
Metabolites detection, integration and quantification 
were done with TraceFinder 3.0 software (Thermo Fisher 
Scientific).
Calculations, tests (Holm–Sidak test, α 0.05, heterosce-
dastic) and graphs (Figs. 4, 5) were performed using Graph-
Pad Prism 7.0 software (GraphPad, CA, USA).
3  Results and discussion
For untargeted metabolomics analysis, an ideal preparation 
method would extract the maximum number of metabolites 
from a large number of samples with high precision. Sam-
ple preparation protocols can be influenced by cell culture 
properties (adherent or suspended, 2D or 3D cultures) as 
well as cell types, the physico-chemical properties of the 
metabolites, and the techniques used for their detection. 3D 
cell cultures were used for this investigation because they 
are now routinely used for toxicological assessment, and a 
new extraction approach was required compared with 2D 
cell cultures.
Understanding the metabolism pathways for xenobiotics, 
such as nicotine and its metabolites, the major markers for 
cigarette smoke exposure, requires precise metabolite analy-
ses, either at individual time points or in kinetic studies. 
To evaluate the precision of a non-discriminative analytical 
approach for intracellular metabolite analysis, sample prepa-
ration effect, matrix factor, and PE were calculated for 16 
metabolites of interest (i.e., nicotine, NNK, and their major 
metabolites) and eight ISTDs related to our research scope. 
Some ISTDs were used for more than one metabolite, based 
on their chemical and physical properties (Table 1).
Fig. 4  Sample preparation effect of ISTDs and analytes with 
no matrices for three classes of metabolites: nicotine, NNK, 
and GSH. The data are mean sample preparation effect values 
for freeze-thawing-based extraction (filled dots) and homoge-
nization-based extraction (unfilled squares). Bars show stand-
ard deviations (n = 6). Analyte recovery values were calculated 
based on analyte concentrations, as quantified using ISTDs. Cot 
cotinine, Diol 1-(3-pyridyl)-1,4-butane diol, Gluc. glucuronide, 
GSH glutathione, HPB 4-hydroxy-1-(3-pyridyl)-1-butanone-4,4, 
Hydroxy acid 1-(3-pyridyl)-1-butanol-4-carboxylic acid, Nic 
nicotine, NNAL 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, 
NNK 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, OPBA 
1-(3-pyridyl)-1-butanone-4-carboxylic acid, Ox oxide
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The addition of ISTDs, which were not present endog-
enously in the samples, enabled evaluation of any changes, 
including signal suppression or enhancement caused by 
sample preparation or analysis, in each extract (Broadhurst 
et al. 2018; Noga et al. 2018). As reported by Broadhurst 
et al. another advantage of including ISTDs in all samples 
was to enable real-time tracking of sample responses dur-
ing data collection (mass accuracy and resolution, retention 
time, peak intensity, and peak shape). This is an advantage 
over the use of QC samples, which are not evaluated until the 
end of a batch or the entire study analysis (Broadhurst et al. 
2018). Absolute quantification of compounds using ISTDs 
enables correction for procedural variations occurring at any 
time after the ISTDs were added to the sample. In our study, 
ISTDs were added at the beginning of sample preparation 
and during cell quenching and extraction to address any 
post-harvesting changes in target metabolites. Results are 
presented for analyte concentrations quantified using the 
ISTDs as well as for the ISTD responses themselves.
A rapid, simple sample preparation method, performed at 
a low temperature to minimize changes in metabolites, was 
evaluated using two different extraction methods.
3.1  Assay procedure
To evaluate sample preparation and the analytical method, 
selected metabolites were injected as pure standards, as 
standards without matrix undergoing sample extraction pro-
cedures, and as standards with matrix undergoing sample 
extraction procedures (Fig. 3). One advantage of cell culture 
Fig. 5  PE (C/A) values for ISTDs and analytes for the three classes 
of metabolites: nicotine, NNK, and GSH. Samples were obtained 
from 3D tissues, HepaRG™ spheroids (upper) or NHBE ALI tis-
sues (lower). Data are means for freeze-thawing-based extrac-
tion (filled dots) and homogenization-based extraction (unfilled 
squares). Bars show standard deviations (n = 6). Data for ana-
lytes were based on concentrations quantified using ISTDs. Cot 
cotinine, Diol 1-(3-pyridyl)-1,4-butane diol, Gluc. glucuronide, 
GSH glutathione, HPB 4-hydroxy-1-(3-pyridyl)-1-butanone-4,4, 
Hydroxy acid 1-(3-pyridyl)-1-butanol-4-carboxylic acid, Nic 
nicotine, NNAL 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, 
NNK 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, OPBA 
1-(3-pyridyl)-1-butanone-4-carboxylic acid, Ox oxide
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is that the environment is controlled, limiting sample-to-
sample variations and enabling robust statistics with a lim-
ited number of replicates (n = 6 in this study) (Dudzik et al. 
2018).
To evaluate sample preparation effects, results obtained 
with pure standard solutions, containing the 16 metabolites 
and the eight ISTDs, were compared with those for the same 
solution subjected to two sample preparation procedures, 
freeze–thawing and homogenization extraction procedures, 
without matrix (Fig. 3).
In an analogous manner, the impact of the matrix, calcu-
lated as a matrix factor, was determined by comparing the 
results obtained for extracted standard solutions with those 
of metabolites and ISTDs spiked on cells during the quench-
ing step (Fig. 3).
Finally, PE was determined by comparing results from 
injected pure standard solutions with those from spiked cell 
samples undergoing the complete sample preparation pro-
cess (Fig. 3).
For endogenous metabolites such as GSH, always present 
in the intracellular metabolome, PE was measured using the 
ISTD only.
3.2  Cell washing, quenching, and extraction
To evaluate the intracellular metabolome, medium was 
removed, and cells were washed to remove medium compo-
nents known to affect the cellular metabolome (Daskalaki 
et  al. 2018). The washed 3D cell cultures were then 
quenched. During all processing, cells were cooled on either 
ice or dry ice.
For the adherent and not homogenous NHBE ALI tis-
sues, cells were harvested from the inserts by scraping into 
cold methanol/water, on ice. Scraping limited metabolite 
leakage, as previously demonstrated with EDTA treatment 
(Dudzik et al. 2018). Samples were then directly extracted 
using two freeze-thaw cycles or one homogenization cycle, 
as described in Sect. 2.5.
3.3  Drying and reconstitution
Drying and reconstitution is commonly used to concen-
trate samples in order to increase the number of metabo-
lites detected. Additionally, samples can be reconstituted in 
solvents other than the extraction solution for compatibility 
with the analytical method.
The impact of the drying step used to concentrate the 
extracts on metabolite detection was quantified by reconsti-
tuting the samples in the same solvent (e.g., the extraction 
mixture [methanol/water, 4:1 v/v]) (Fig. 2). The concentra-
tion procedure substantially decreased the responses for 
nicotine, nornicotine, GSH, and their corresponding ISTDs. 
For instance, after overnight drying nornicotine D4 showed a 
very good relative standard deviation (RSD) in the calibra-
tion solutions (RSD = 3%), while for samples been through 
the extraction processes (freeze-thawing or homogeniza-
tion) the RSD were high (between 24 and 72%), for both cell 
types. Additionally, the nicotine  D3 PEs were low (between 
18% for HepaRG™ spheroids after homogenization, to 54% 
for NHBE ALI tissues after freeze-thawing). While drying 
overnight led to consistent signal decreases in all samples, 
a duration of 2 h resulted in high variability in the data. 
For example, nicotine  D3 was not detected in samples after 
overnight drying, while nicotine  D3 was detected in 61% of 
the samples dried 2 h.
High response variability or absence of the ISTD drasti-
cally impacts quantification of the metabolites, if they are 
detected. Because of the significant signal decrease or vari-
ability caused by drying, this step was not included in sub-
sequent experiments. After extraction and centrifugation, 
samples were instead directly transferred to LC-HRMS vials 
for analyses (Fig. 2).
If a drying step is required to concentrate an extract or 
modify solvent composition, ISTDs must be added to correct 
for any metabolite changes caused by drying.
3.4  Method performance
To evaluate sample preparation effect without matrix, the 
ratio between compound responses observed in a standard 
solution processed by the two extraction procedures were 
compared with those in pure standard solutions (Fig. 3).
There were no significant differences between the two 
extraction procedures in analysis of the ISTDs (Holm–Sidak 
test, α 0.05, heteroscedastic). The mean sample preparation 
effect values (n = 6) for the ISTDs were between 97.3 ± 2.8% 
(for 4-hydroxy-1-(3-pyridyl)-1-butanone  D2 [HPB-D2]) and 
110.8 ± 1.2% (for nornicotine D4), both after the homogeni-
zation process, as shown in Fig. 4 (left). The analytes were 
quantified using their corresponding ISTDs (Table 1), and 
no significant differences were observed between the two 
extraction processes (Holm–Sidak test, α 0.05, heteroscedas-
tic). The mean sample preparation effect values (n = 6) for 
the analytes were between 94.8 ± 3.6% for nornicotine (after 
the freeze-thawing process) and 103.3 ± 1.6% for 3-hydroxy-
cotinine-O-glucuronide (OH Cot-Gluc, after the homogeni-
zation process), as shown in Fig. 4 (right).
As detailed above, without matrix, sample preparation 
recoveries were good for ISTDs and analytes, with accurate, 
reproducible results and no significant differences between 
the two extraction procedures.
To evaluate the impact of extraction procedures on metab-
olites from NHBE ALI tissues and HepaRG™ spheroids, 
PE was calculated by comparing results from spiked cell 
cultures to those from pure standard solutions (Fig. 3).
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For the ISTDs, PE values were calculated by dividing 
the area obtained for each ISTD from spiked matrices by 
that from pure standard solutions. For HepaRG™ sphe-
roids, PE values were between 62.7 ± 5.3% (nicotine-N-glu-
curonide D3, Nic-N-Gluc. D3) and 95.5 ± 9.9% (HPB  D2) 
using homogenization (Fig. 5, upper left). For NHBE ALI 
tissues, Nic-N-Gluc. D3 was detected with lowest efficien-
cies (61.7 ± 15.3% and 71.7 ± 9.1% for homogenization and 
freeze-thawing, respectively), as shown in Fig. 5 (lower left).
For the analytes, PE values were calculated using concen-
trations quantified with ISTDs in spiked matrices divided by 
those measured in pure standard solutions. Of the metabo-
lites, nornicotine had the lowest PE value in HepaRG™ 
spheroids (83.2 ± 6.7% and 77.8 ± 6.0% for homogeniza-
tion and freeze-thawing, respectively) as well as in NHBE 
ALI tissues (94.2 ± 2.6% and 95.5 ± 6.3% for homogeniza-
tion and freeze-thawing, respectively) (Fig. 5, right). The 
highest PE values were obtained in both matrices and 
extraction procedures for 1-(3-pyridyl)-1-butanone-4-car-
boxylic acid (OPBA) in NHBE ALI tissues (113.0 ± 3.0% 
and 115.7 ± 6.3% for homogenization and freeze-thawing, 
respectively) and in HepaRG™ spheroids (112.3 ± 2.7% 
and 115.2 ± 6.9% for homogenization and freeze-thawing, 
respectively) (Fig. 5, right).
The results for OPBA analysis were explained by the 
use of a non-isotopologue ISTD, HPB D2, a stable isotope-
labelled compound with a molecular structure that is close, 
but not exactly the same. When the ISTDs and analytes 
were isotopologues, the analyte PE values were nearly 
100%, as shown for nicotine-N-glucuronide in HepaRG™ 
spheroids (97.5 ± 4.1% and 99.5 ± 3.3% for homogeniza-
tion and freeze-thawing, respectively) and in NHBE ALI 
tissues (101.0 ± 2.4% and 101.0 ± 4.2% for homogeniza-
tion and freeze-thawing, respectively). In contrast, Nic-N-
Gluc D3 analysis had the lowest PE values in homogenized 
HepaRG™ spheroids (62.7 ± 5.3%) and in NHBE ALI tis-
sues (61.7 ± 15.3% and 71.7 ± 9.1% for homogenization and 
freeze-thawing, respectively). Such results illustrated the 
importance of using appropriate ISTDs to correct for signal 
losses or enhancement during sample preparation and data 
acquisition. Without ISTDs, the true metabolite concentra-
tion cannot be determined (Broadhurst et al. 2018).
As shown in Fig. 3, the PE value is a combination of 
sample preparation effect and matrix factor. Our results 
indicated that our sample preparation procedures yielded 
accurate and reproducible results for all metabolites, inde-
pendently of the extraction process used. The matrix effects 
(not shown) showed similar trends as the PE values. Thus 
the loss or enhancement of some ISTDs and metabolites 
detected, based on PE values, were caused by the presence 
of the matrices.
For extraction of cell cultures, monolayers, or tissues, 
use of freeze-thawing cycle(s) or physical disruption 
(homogenization or ultrasonication) have been reported in 
literature without studies comparing these methods. Here, 
we compared freeze-thawing and homogenization extraction 
procedures to evaluate the most suitable sample preparation 
methods, based on recovery, efficiency, and repeatability. 
The two extraction procedures showed no significant differ-
ences in recovery, repeatability, and efficiency (Figs. 4, 5).
For sample preparation, extraction by homogenization 
required only 2 min, compared with approximatively 1 h 
required for extraction by freeze-thawing. However, the pres-
ence of beads used for homogenization required an addi-
tional transfer step to obtain clean extracts, separated from 
beads, protein, and cell debris. Without a drying–reconstitu-
tion step, both sample preparation techniques are simple and 
fast and comparable with “dilute and shoot” methods applied 
for the analysis of homogenous matrices (e.g., urine). Rapid, 
simple measures should decrease the risk of changes in the 
metabolome during sample preparation.
4  Conclusions
These results demonstrated the importance of using ISTDs 
to correct for signal losses or enhancements caused by the 
presence of matrices. We showed that structurally related 
ISTDs can enable partial compensation for metabolite losses 
or enhancements, while isotopologue ISTDs enable full 
compensation for such artifacts. Additionally, the resulting 
ability to absolutely quantify analytes will improve inter-
study and inter-laboratory comparisons.
Among the tobacco-related metabolites evaluated, the 
results for some were strongly affected by a drying–recon-
stitution step, some metabolites or ISTDs such as nicotine 
and nicotine  D3 were not always detected after a drying step. 
For other compounds such as nornicotine, the drying step 
induced high RSD and low recoveries. By eliminating this 
step, favorable recoveries were obtained for those analytes. 
Furthermore, for all compounds assessed, there were no sig-
nificant differences between homogenization- and freeze-
thawing-based extractions.
The sample preparation methods evaluated here were 
rapid, easily performed, and gave repeatable results due to 
the ISTDs’ for complex adherent and suspended 3D cell cul-
tures. The metabolite list is flexible, expendable and cus-
tomizable according to study needs; thus the protocols and 
method presented herein can be useful for metabolomics 
investigation.
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